Involvement of membrane type 1-matrix metalloproteinase (MT1-MMP) in RAGE activation signaling pathways

Masashi Kamioka1, Toshiyuki Ishibashi, Hiroshi Ohkawara

  • 1Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan.

Insights

Advanced glycation end products (AGE) and the receptor for AGE (RAGE) axis contribute to diabetic vascular issues. Membrane type 1-matrix metalloproteinase (MT1-MMP) is crucial in AGE/RAGE signaling pathways, suggesting it as a therapeutic target.

Area of Science:

  • Vascular Biology
  • Molecular Medicine
  • Biochemistry

Background:

  • The advanced glycation end products (AGE)/receptor for AGE (RAGE) axis is implicated in diabetic vascular complications.
  • Membrane type 1-matrix metalloproteinase (MT1-MMP) acts as both a proteolytic enzyme and a signaling molecule.

Purpose of the Study:

  • To investigate the role of MT1-MMP in AGE/RAGE-triggered signaling pathways in smooth muscle cells (SMCs).
  • To explore the molecular interaction between RAGE and MT1-MMP in vitro and in vivo.

Main Methods:

  • Utilized cultured rabbit SMCs and diabetic rat aortae.
  • Employed small-interfering RNA (siRNA) for gene silencing.
  • Performed fluorescent immunohistochemistry and immunoprecipitation.

Main Results:

  • AGEs activated Rac1, NADPH oxidase, reactive oxygen species (ROS) generation, and NF-κB phosphorylation in SMCs.
  • MT1-MMP silencing attenuated AGE-induced signaling, including geranylgeranyl transferase I (GGTase I) activity.
  • RAGE and MT1-MMP were found to co-localize and form complexes in SMCs and vascular tissues.

Conclusions:

  • MT1-MMP plays a critical role in RAGE-activated NADPH oxidase-dependent signaling pathways.
  • MT1-MMP forms a complex with RAGE in the vasculature.
  • MT1-MMP represents a potential novel therapeutic target for diabetic vascular complications.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...